We are live on ! Find out more
PAHC icon

Phibro Animal Health

141 hedge funds and large institutions have $337M invested in Phibro Animal Health in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 58 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,214% more call options, than puts

Call options by funds: $92K | Put options by funds: $7K

28% more capital invested

Capital invested by funds: $264M → $337M (+$73.6M)

24% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 17

2% more funds holding

Funds holding: 138141 (+3)

1.34% less ownership

Funds ownership: 100.25%98.91% (-1.3%)

22% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 58

Holders
141
Holders Change
+3
Holders Change %
+2.17%
% of All Funds
2.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
45
Reduced
58
Closed
17
Calls
$92K
Puts
$7K
Net Calls
+$85K
Net Calls Change
-$24K
Name Holding Trade Value Shares
Change
Change in
Stake
DAS
151
Dynamic Advisor Solutions
Arizona
-$145K -11,234 Closed
Cerity Partners
152
Cerity Partners
New York
-$143K -11,094 Closed
AIG
153
American International Group
New York
-$143K -11,024 Closed
CC
154
Centiva Capital
New York
-$140K -10,818 Closed
QT
155
Quantbot Technologies
New York
-$36.2K -2,800 Closed
ACM
156
Aquatic Capital Management
Illinois
-$19.4K -1,500 Closed
MLICM
157
Metropolitan Life Insurance Company (MetLife)
New York
-$14.7K -1,140 Closed
Northwestern Mutual Wealth Management
158
Northwestern Mutual Wealth Management
Wisconsin
-$233 -18 Closed

PAHC Hedge Fund Activity: Q2 2024 in Review

141 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q2 2024, worth a combined $337M — up 28% from $264M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new PAHC positions and 17 closed out — a net gain of 4 holders — while 45 added to existing stakes and 58 trimmed.

The largest buyer was Sofinnova Investments, opening a new position worth an estimated $3.81M. The largest seller was Hotchkis & Wiley Capital Management, cutting an estimated $2.7M.

  • 141 institutional investors held Phibro Animal Health (PAHC) as of Q2 2024, up from 138 in Q1 2024.
  • Funds reported $337M of Phibro Animal Health stock for Q2 2024, up 28% quarter-over-quarter.
  • 21 funds opened new Phibro Animal Health positions in Q2 2024 and 17 closed out, a net change of +4 holders.
  • The largest Phibro Animal Health buyer in Q2 2024 was Sofinnova Investments, an estimated $3.81M added.
  • The largest Phibro Animal Health seller in Q2 2024 was Hotchkis & Wiley Capital Management, an estimated $2.7M sold.

Based on aggregated 13F filings for Q2 2024.